APP and Alzheimer disease: Preclinical and clinical studies have demonstrated that citalopram and escitalopram are not only anti-depressive and anxiolytic in AD patients but also reduce the toxic effects of amyloid precursor protein and Aβ in AD and other amyloid-related disorders [143,149,150,151,152,153,154].